Training in HIV/AIDS Prevention and Treatment Research in Botswana
博茨瓦纳艾滋病毒/艾滋病预防和治疗研究培训
基本信息
- 批准号:9975952
- 负责人:
- 金额:$ 30.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAIDS/HIV problemAcquired Immunodeficiency SyndromeAdvisory CommitteesAfricaAnti-Retroviral AgentsBotswanaCountryDeveloping CountriesDoctor of PhilosophyEducational workshopEnvironmentEpidemicFacultyFundingGoalsGovernmentHIVHealthHigh PrevalenceIndividualInstitutesInstitutionJournalsModernizationMonitorPatientsPerformancePharmacotherapyPositioning AttributePostdoctoral FellowPreventionPrevention ResearchPublic Health SchoolsPublicationsResearchResearch ActivityResearch PersonnelResearch TrainingSafetySiteTeacher Professional DevelopmentTestingTrainingTraining ProgramsTreatment outcomeUniversitiesbaseexperiencefaculty mentorlow and middle-income countriespre-doctoralprogramssuccesstraining opportunitytreatment programtreatment research
项目摘要
PROJECT ABSTRACT
The focus for this proposal is research training for people from Botswana in relation to the various uses of ART
for prevention and treatment in the modern era of the HIV epidemic. Recent advancements in coverage
strategies and antiretroviral combinations within the Botswana national ART program offer a unique
environment for use of modern HIV treatment, safety, and prevention research for the developing world, with a
host of research opportunities for training researchers in Botswana, to match current research activities of the
faculty mentors and key partners at the Botswana site. The in-country institution for this proposal is the
Harvard T.H. Chan School of Public Health, and our LMIC partner for training is the Botswana Harvard AIDS
Institute Partnership (BHP), a limited liability nonprofit corporation (LLC) with the Ministry of Health (MOH) in
Botswana. BHP is the largest HIV/AIDS research organization in Botswana, and one of the largest in Africa.
The long-term goals and objectives of this training program are to train research leaders for BHP, the
University of Botswana, and the MOH. Botswana currently has one of the highest prevalence rates of HIV in
the world (22%), but has also had the highest rate of antiretroviral drug treatment (ART) for patients with HIV
(about 90%) in Africa. The government of Botswana currently operates the most advanced HIV treatment
program in Africa, using a universal test-and-treat strategy. The training faculty at Harvard and BHP will focus
on how “modern” ART impacts treatment outcomes, safety, and prevention research.
HIV-related courses, seminars, and workshops are available for trainees. We have requested funds for 2
predoctoral and 3 postdoctoral positions each year. We estimate that we will train about 18 trainees over 5
years, allowing for multiple years for each PhD candidate and some postdoctoral fellows, and assuming
several short-term trainees could fill a single annual training slot. Stipends will be based on current degrees
and research experience; thus an MD on an MS or PhD program would be eligible for a postdoctoral-level
stipend. Each trainee will have a principal advisor and a faculty advisory committee. Selection of trainees is
based on previous academic performance, references, experience, and assurance that the candidates will
return to participate in HIV research in Botswana. The quality of the program will be monitored by a Training
Advisory Committee composed of experts from the US and from developing countries. The success of the
training program will be judged by the relative increase in senior research positions at BHP, UB, and MOH that
are individuals who were trained by this program after the second and fourth years. Success will also be
judged by the implementation of successful prevention research programs that involve trainees, numbers of
trainee publications in high-impact journals, and number of staff positions filled by former trainees at the BHP
and the Ministry of Health.
项目摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHAHIN LOCKMAN其他文献
SHAHIN LOCKMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHAHIN LOCKMAN', 18)}}的其他基金
Addressing Major HIV Prevention and Health Outcomes Questions in an Era of Universal ART: Mentoring in a Community-Randomized Trial
解决普遍抗逆转录病毒治疗时代的主要艾滋病毒预防和健康结果问题:社区随机试验中的指导
- 批准号:
10112810 - 财政年份:2017
- 资助金额:
$ 30.06万 - 项目类别:
Mentoring in Global Patient-Oriented HIV Research in the Era of COVID-19 and Universal ART
COVID-19 和通用 ART 时代全球以患者为导向的艾滋病毒研究的指导
- 批准号:
10483694 - 财政年份:2017
- 资助金额:
$ 30.06万 - 项目类别:
Mentoring in Global Patient-Oriented HIV Research in the Era of COVID-19 and Universal ART
COVID-19 和通用 ART 时代全球以患者为导向的艾滋病毒研究的指导
- 批准号:
10669765 - 财政年份:2017
- 资助金额:
$ 30.06万 - 项目类别:
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana
博茨瓦纳艾滋病毒暴露婴儿的短期母乳喂养和复方新诺明
- 批准号:
9073896 - 财政年份:2015
- 资助金额:
$ 30.06万 - 项目类别:
Training in HIV Genomics, Treatment, and Cure Research in Botswana
博茨瓦纳的艾滋病毒基因组学、治疗和治愈研究培训
- 批准号:
10688707 - 财政年份:2013
- 资助金额:
$ 30.06万 - 项目类别:
Training in HIV/AIDS Prevention and Treatment Research in Botswana
博茨瓦纳艾滋病毒/艾滋病预防和治疗研究培训
- 批准号:
10396618 - 财政年份:2013
- 资助金额:
$ 30.06万 - 项目类别:
Training in HIV/AIDS Prevention and Treatment Research in Botswana
博茨瓦纳艾滋病毒/艾滋病预防和治疗研究培训
- 批准号:
10161878 - 财政年份:2013
- 资助金额:
$ 30.06万 - 项目类别:
Training in HIV/AIDS Prevention and Treatment Research in Botswana
博茨瓦纳艾滋病毒/艾滋病预防和治疗研究培训
- 批准号:
10462051 - 财政年份:2013
- 资助金额:
$ 30.06万 - 项目类别:
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana
博茨瓦纳艾滋病毒暴露婴儿的短期母乳喂养和复方新诺明
- 批准号:
8316378 - 财政年份:2010
- 资助金额:
$ 30.06万 - 项目类别:
Short Breastfeeding and Cotrimoxazole among HIV-Exposed Infants in Botswana
博茨瓦纳艾滋病毒暴露婴儿的短期母乳喂养和复方新诺明
- 批准号:
8144267 - 财政年份:2010
- 资助金额:
$ 30.06万 - 项目类别: